Odonate Therapeutics



Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer

Jennifer Schroeder
Vice President of Program Management and Technology
Jill Krause
Vice President of Medical Affairs
John Lemkey
Chief Operating Officer
Joseph O’Connell
Chief Medical Officer
Kim Ma
Vice President of Clinical Operations, Pacific
Michael Hearne
Chief Financial Officer
Natasha Bartasch-Price
Vice President of Regulatory Operations
Ryan Cole
Vice President of Operations
Steven Pfeiffer
Vice President of Technical Operations
Stew Kroll
Chief Development Officer
Thomas Wei
Chief Scientific Officer
Tracey McKennon
Vice President of Quality Assurance

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.